- UK study finds limited waning in vaccine effectiveness against Covid-19–related hospitalization and death at 20 weeks or more after vaccination with two doses of the ChAdOx1-S or BNT162b2 vaccine. Waning was greater in older adults and in those in a clinical risk group. https://www.nejm.org/doi/full/10.1056/NEJMoa2115481?query=featured_home 14 comments science
Linking pages
- BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age: Cell Reports https://www.cell.com/cell-reports/fulltext/S2211-1247(22)01400-0 75 comments
- Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2200797 43 comments
- Will Omicron Leave Most of Us Immune? - The Atlantic https://www.theatlantic.com/health/archive/2022/01/omicron-wave-immunity/621324/ 13 comments
- Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2 https://www.mdpi.com/2076-393X/10/12/2146 4 comments
Linked pages
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2108891 50 comments
- Waning Immunity after the BNT162b2 Vaccine in Israel | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2114228 0 comments
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2114114 0 comments
- Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2110362 0 comments
- VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2208822 0 comments
Related searches:
Search whole site: site:www.nejm.org
Search title: Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines | NEJM
See how to search.